Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,797,481
-$1,627,443 QoQ
Shares Held
248,819
-33.0% QoQ
Ownership
0.337%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.98271836153991.ToString("F0")%
Shared 0.ToString("F0")%
None 0.017281638460085444.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. INVA ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,797,481 | 248,819 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,424,924 | 371,432 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,427,126 | 735,733 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,524,144 | 1,021,610 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,058,374 | 1,161,521 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,619,924 | 842,647 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,706,983 | 658,052 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,815,225 | 659,465 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,197,285 | 734,730 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,367,128 | 771,018 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,230,992 | 710,623 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,835,429 | 615,509 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,719,840 | 686,208 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,973,393 | 979,124 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,824,246 | 932,321 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,029,113 | 1,153,734 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,457,269 | 1,212,262 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,782,629 | 798,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,804,130 | 826,100 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,208,868 | 835,859 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,540,306 | 1,049,398 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,180,615 | 1,144,521 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,905,415 | 1,234,968 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $18,896,444 | 1,351,677 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $18,052,716 | 1,535,095 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||